Clinical trial
AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic…
NCT00372736 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00372736 |
|---|---|
| Title | AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors |
| Official title | A Phase I Study of AEG35156 Given as a 2 Hour Intravenous Infusion in Combination With Docetaxel in Patients With Solid Tumours |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Genetic, Other |
| Interventions | AEG35156, docetaxel, protein expression analysis, reverse transcriptase-polymerase chain reaction, flow cytometry, immunoenzyme technique, immunohistochemistry staining method, laboratory biomarker analysis |
| Enrollment | 27 |
| Start date | Jul 27, 2006 |
| Primary completion | Mar 24, 2009 |
| Completion | Jan 6, 2012 |
| First posted | Sep 7, 2006 |
| Last update posted | Aug 4, 2023 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: